best glp-1 medication Researchers move closer to matching patients with drug that works for them it’s the perfect companion for anyone using GLP What to Make of the

Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 20202023

Many plans specifically exclude weight loss medications regardless of FDA approval

Food and Drug Administration for safety, effectiveness, and manufacturing quality

Ongoing research and patient education will further enhance our ability to address and mitigate these side effects, ensuring a better quality of life for those on this medication

Studies in the New England Journal of Medicine confirm that continuous GLP-1 therapy maintains weight loss, while discontinuation leads to predictable regain regardless of diet adherence

We conducted a meta-analysis, considering a total of 10 original studies